Novartis Czech Republic - Total Cash From Operations

Novartis Czech Republic`s Total Cash From Operations reached -16.5 CZK mil in 2017. This is 126 % less than in the previous year.

$1.99

Buy Total Cash From Operations data for Novartis Czech Republic.

$19.99

Buy all data for Novartis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ... ...           52.0 20.0 81.2 -43.7 130    
Bayer Czech Republic ... ... ...             ... ... ... ... ... ... ...    
GlaxoSmithKline Czech Republic ... ... ...           ... ... ... ... ... ... ... ...    
Merck Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...    
Novartis Czech Republic                       -113 167 80.7 90.3 155    
Pfizer Czech Republic ... ...             ... ... ... ... ... ... ... ...    
Roche Czech Republic ... ... ...                 65.2 159 127 66.8 -4.71   ...
Sanofi-Aventis Czech Republic ... ... ... ...               58.5 -155 460 404 70.6    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 15.4 15.4 -0.624 -11.7    
Walmark ... ... ...                 200 150 167 154 -349